Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.
Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors
Breast cancer statistics, 2013
Signal Transduction by Receptor Tyrosine Kinases
Signaling by Receptor Tyrosine Kinases
Targeting Apoptosis Pathways in Cancer Therapy
Novel Agents on the Horizon for Cancer Therapy